 |
|
The Role of Bisphosphonates Prior to Denosumab Treatment on Rebound Fractures: A Mini Review
Arthur Costa Inojosa, Laís Mendes, Leonardo Bandeira, Francisco Bandeira
J Bone Metab. 2022;29(4):217-223. Published online 2022 Nov 30 DOI: https://doi.org/10.11005/jbm.2022.29.4.217
|
|
Citations to this article as recorded by
 Multiple vertebral fractures after antiosteoporotic medications discontinuation: A comparative study to evaluate the potential rebound effect of denosumab
Mar Martín-Pérez, Beatriz Sánchez-Delgado, Patricia García-Poza, Sergio López-Álvarez, Elisa Martín-Merino
Bone.2025; 190: 117325. CrossRef Denosumab for osteoporosis treatment: when, how, for whom, and for how long. A pragmatical approach
Olivier Lamy, Judith Everts-Graber, Elena Gonzalez Rodriguez
Aging Clinical and Experimental Research.2025;[Epub] CrossRef The use of denosumab in osteoporosis – an update on efficacy and drug safety
Dima L. Diab, Nelson B. Watts
Expert Opinion on Drug Safety.2024; 23(9): 1069. CrossRef
|